Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jueling Mingmu decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for eye health, particularly in the management of macular cystoid edema secondary to retinal vein occlusion. It is administered as a water-based herbal decoction and often used in combination with standard pharmaceutical treatments such as ranibizumab. The formula consists of multiple herbs traditionally believed to nourish the liver and kidneys, clear heat, dispel wind, and improve vision according to TCM theory. Its mechanism of action from a biomedical perspective is not fully elucidated but may involve anti-inflammatory effects, antioxidative stress reduction, and modulation of cellular senescence pathways relevant to ocular tissue health[1]. Clinical studies are ongoing to evaluate its efficacy and safety when combined with conventional therapies for retinal diseases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jueling Mingmu decoction.